Gossamer Bio, Inc. GOSS Q2 2026 earnings

FAQ

When did Gossamer Bio, Inc. report Q2 2026 earnings?

Gossamer Bio, Inc. (GOSS) reported Q2 2026 earnings on August 13, 2026 after market close.

What were Gossamer Bio, Inc.'s Q2 2026 revenue and EPS?

Gossamer Bio, Inc. reported revenue of $9.2M and eps of $-0.08 for Q2 2026.

Did Gossamer Bio, Inc. beat estimates in Q2 2026?

Revenue beat the consensus estimate of $3.6M by $5.6M. EPS beat the consensus estimate of $-0.12 by $0.04.

How did Gossamer Bio, Inc.'s Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 19.6% from $11.5M a year earlier and eps grew 52.9% from $-0.17.

Where can I find Gossamer Bio, Inc.'s Q2 2026 SEC filings?

You can read the 8-K earnings release (0001728117-26-000073) and the 10-Q periodic report (0001728117-26-000072) directly on SEC EDGAR. The filing index links above go to sec.gov.